Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202987 Hepatitis virus; oligomer protein
10/30/2003US20030202978 Spray freeze-dried compositions
10/30/2003US20030202961 Methods of therapy for HIV infection
10/30/2003CA2484384A1 Preventives for hiv infection
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2483227A1 Antiviral inhibition of capsid proteins
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482715A1 Antiviral lactone-ureas
10/30/2003CA2482593A1 Combination of an agent that attenuates topoisomerase 1 activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
10/30/2003CA2482439A1 Use of topical compositions for the control of microbial diseases of the nail
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481786A1 Methods of treating necrotizing enterocolitis
10/30/2003CA2481108A1 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003CA2481088A1 Use of materials having zinc ionophoric behavior
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2478009A1 Modified vaccinia virus ankara for the vaccination of neonates
10/30/2003CA2384474A1 Compositions and methods for protecting against sexually transmitted diseases
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357127A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes
10/29/2003EP1357123A1 Novel carbapenem compounds
10/29/2003EP1357122A2 Oxazolidinone compounds and pharmaceutical compositions containing them
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1356822A2 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356813A1 Antibacterial compositions comprising metal phthalocyanine analogues
10/29/2003EP1356733A2 Pesticidal and antiparasitic compositions
10/29/2003EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9
10/29/2003EP1356287A2 Replication assay for detecting anti-viral substances
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356070A2 Conditionally replicating viral vectors and their use
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1355947A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355873A1 Pleuromutilin derivatives with antimicrobial activity
10/29/2003EP1355676A2 Protecting therapeutic compositions from host-mediated inactivation
10/29/2003EP1355673A2 Multivalent meningococcal polysaccharide-protein conjugate vaccine
10/29/2003EP1355672A2 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355663A1 Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment
10/29/2003EP1355653A2 Stimulation of thymus for vaccination development
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355629A1 Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids
10/29/2003EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1032265B1 New psoralens for pathogen inactivation
10/29/2003EP1011692B1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY
10/29/2003EP1007527B1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0843663B9 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
10/29/2003EP0758240B1 Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
10/29/2003EP0745128B1 Hepatitis b virus mutants, reagents and methods for detection
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/29/2003EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452634A HLA binding peptides and their uses
10/29/2003CN1452627A 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
10/29/2003CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452611A 13-substd. methacycline compounds
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1452495A Vaccine against microbial pathogens
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452488A Treatment of inflammatory disorders
10/29/2003CN1452487A Antimicrobial composition and mthod for producing same
10/29/2003CN1452486A Pharmaceutical composition and use method
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451747A Medusa cystatin gene, and expression and use thereof
1 ... 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 ... 1798